Learn How

Learn how AI can help HCOs promote early diagnosis of COPD, slow COPD progression, and avoid adverse events and complications. Discover how AI can help to identify undiagnosed or early-stage COPD, identify opportunities for improved patient engagement, and predict individuals likely to experience potentially preventable hospitalization and other adverse events.

Automatically ingest data from dozens of health data sources including...

Remote Monitoring Data

Remote monitoring data capture key vital signs and health behaviors (e.g. blood pressure, heart rate, blood glucose, activity levels, etc.).

Social Needs Assessments

Self-reported data that identify an individual's specific needs and the acute social and economic challenges they are experiencing.

Electronic Health Records

EHR data with comprehensive patient histories of vital signs and symptoms, problem lists and chief complaints, tests results, diagnoses and procedures, and prescriptions.

Closedloop icon with a line

ClosedLoop generates explainable predictions using

thousands of auto-generated, clinically relevant contributing factors

Martin Tyson
69-Year-Old Male
Risk of ER visit or admission due to COPD exacerbation in the next 12 months
Risk Score Percentile
Impact on Risk  |  Contributing Factor
+24% | Decline in Average Oxygen Saturation (Spo2 Pct)
94% to 89%
+17% | # of ER Visits (12M)
+13% | Increase in Supplemental Oxygen (liters / min)
2 to 4
+9% | Increase in Social Isolation (outings / week)
3 to 1

What Is COPD?

Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of death in the United States, affecting nearly 16 million Americans.¹ In 2018, chronic lower respiratory diseases—primarily COPD—were responsible for over 150,000 deaths.² But despite the remarkable prevalence and lethality of COPD, awareness is alarmingly low; more than 50% of adults with low pulmonary function were not aware that they had COPD.³ 

Why It Matters

Barriers to awareness and timely diagnosis of COPD stem from a number of sources: COPD may be inaccurately diagnosed as another respiratory disease or obscured by potential comorbidities.⁴ However, accurately identifying COPD early and staging proactive interventions is critical to both improving quality of life for patients and reducing the significant $32 Billion economic burden COPD poses.⁵

AI Presents an Opportunity

AI-based models are ideally suited to identify patients at high-risk for COPD. Organizations can leverage predictive analytics to enroll these patients in self-management programs that prioritize patient engagement and continuity of care. Self-management interventions in COPD patients are beneficial for reducing hospitalizations, and patients with higher continuity of care have a lower likelihood of avoidable hospitalization.⁶𝄒⁷ Ultimately, reducing hospitalizations for COPD patients corresponds to improved health outcomes and reduced cost. With proper management, most people with COPD can achieve good symptom control and quality of life, as well as reduce their risk of other associated conditions including heart disease and lung cancer.

Did You Know…

  • 16 million Americans are affected by COPD¹
  • 50% of adults with low pulmonary function were unaware they had COPD³ 
  • $49 Billion is the projected annual cost attributed to COPD⁵
  • One death every four minutes in the United States is directly attributed to COPD²
Citations & Footnotes

1. Wheaton, Anne G., et al. “Employment and activity limitations among adults with chronic obstructive pulmonary disease — United States, 2013.” Morbidity and Mortality Weekly Report, vol. 64, no. 11, Mar. 2015, pp. 289–295. DOI: PMC4584881

2. CDC. “Chronic Obstructive Pulmonary Disease (COPD) Includes: Chronic Bronchitis and Emphysema.” Centers for Disease Control and Prevention, 30, Oct. 2020, https://www.cdc.gov/nchs/fastats/copd.htm. Accessed 26 Nov. 2020. 

3. Mannino DM, et al. “Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey 1988-1994.” Arch Intern Med, vol. 160, no. 11, Jun. 2000, pp.1683–1689. DOI: 10.1001/archinte.160.11.1683

4. Yawn, Barbara, and Wollan, Peter. “Knowledge and attitudes of family medical professionals coming to COPD continuing medical education.” International Journal of Chronic Obstructive Pulmonary Disease, vol. 3, no. 2, Jun. 2008, pp. 311–317. DOI: 10.2147/copd.s2486

5. Ford, Earl S., et al. "Total and state-specific medical and absenteeism costs of COPD among adults aged 18 years in the United States for 2010 and projections through 2020." Chest vol. 147, no. 1, Jan. 2015, pp. 31-45. DOI: 10.1378/chest.14-0972

6. Jonkman, Nini, et al. “Do Self-Management Interventions in COPD Patients Work and Which Patients Benefit Most? An Individual Patient Data Meta-Analysis.” International Journal of Chronic Obstructive Pulmonary Disease, vol. Volume 11, Aug. 2016, pp. 2063–2074, 10.2147/copd.s107884.

7. Lin, I.-P. et al. "Continuity Of Care And Avoidable Hospitalizations For Chronic Obstructive Pulmonary Disease (COPD)". The Journal Of The American Board Of Family Medicine, vol 28, no. 2, 2015, pp. 222-230. American Board Of Family Medicine (ABFM), doi:10.3122/jabfm.2015.02.140141.

ClosedLoop is an exciting and important partner in our strategy to develop timely predictive insights through operationalized AI solutions that will drive member engagement and better health outcomes.

Pat Wang
President & CEO, Healthfirst
Klas image

ClosedLoop's healthcare expertise was a big deal to us. It didn’t take a lot to translate things, and they adapted their approach to create a predictive model for our unique interest in the data streams.

Anonymous Customer CEO
KLAS Analyst Report

We are extremely impressed with the predictive modeling capabilities the ClosedLoop platform has delivered. The ClosedLoop team has exceeded all defined goals and benchmarks set to date and we anticipate a substantial return on our investment as these predictions are operationally deployed.

Cheryl Lulias
President & Executive Director, MHN
Klas image

We wanted to use the product for population health and SDOH. The things we can do with the ClosedLoop product are unlimited.

Anonymous Customer
KLAS Analyst Report

Over the course of my career, there has never been an opportunity like this. The need for efficiency is a daunting challenge. The capacity of predictive AI technology drives our efficiency and will have a lasting impact on our ability to help PCPs improve the quality of health outcomes while reducing health disparities.

Dr. Jim Walton
President & CEO, Genesis Physicians Group

Learn What ClosedLoop Can Do for Your Organization

The industry’s best collection of customizable predictive models for common healthcare use cases.

Talk To An Expert